The interventional pulmonology department at Cancer Treatment Centers of America® (CTCA), Phoenix performs advanced, minimally invasive diagnostic, therapeutic and palliative procedures for lung cancer patients and those experiencing respiratory disease or infection. The interventional pulmonologists at CTCA® Phoenix help diagnose and treat cancer and benign pulmonary diseases.
Many of the interventional pulmonology procedures offered at our Phoenix hospital are performed on an outpatient basis, under conscious sedation or general anesthesia for patient comfort. Using state-of-the-art diagnostic tools and minimally invasive procedures, the interventional pulmonologists at the Arizona cancer center locate and stage the disease before starting treatment. One advanced interventional pulmonology service offered at CTCA is the endobronchial ultrasound, used to stage lung cancer. Instead of making an incision in the neck to expose the lymph nodes, a bronchoscope with an ultrasound probe is used to explore the area. Navigational bronchoscopy is another technique performed at the Phoenix hospital. It involves directing a steerable catheter through a bronchoscope to view masses that cannot be seen in the airway.
Dr. Wissam Jaber is Director of Interventional Pulmonary Medicine at CTCA Phoenix. Dr. Jaber is board certified in internal medicine, pulmonary disease and critical care medicine by the American Board of Internal Medicine. As an interventional pulmonologist, he has advanced training in diagnostic and therapeutic procedures for lung and thoracic cancers. Dr. Jaber integrates minimally invasive techniques into the diagnosis of cancer and the treatment of conditions of the lungs and airways resulting from cancer. He and other members of his interventional pulmonology team meet with patients to discuss individualized plans and treatment goals. Patients are informed of their treatment options and potential side effects and work with Dr. Jaber to select the most appropriate regimen.